Markets
local & international
Asia Pacific
Currencies
Commodities
UK
North America
News
latest news
Latest News
Most Viewed
Business
Currencies
Economy
Markets
Property
Technology
Portfolio
analysis & tools
Portfolios
Alerts
Filters
Reports
Watchlists
Help
Products
products & services
Charting
Data Agent
Data Subscriptions
Historical Data
Investment Game
Pricing
Real Edge
Download
Login
Register
Saturday, 20 April 2024
Zillow Group Inc.
NASDAQ
ZG
Summary
|
Chart
|
News
|
History
|
More info..
NASDAQ : ZG
27.02
14 Oct 22 00:00
Change:
1.08
Open:
28.92
High:
29.18
Ask:
0.00
Volume:
464,100
Change(%):
3.84
Prev:
28.10
Low:
26.81
Bid:
0.00
Avg vol:
0
Latest News
More news...
Zillow Group, Inc. (Z) estimated to arrive at $47.75 in 1 Year period
03:37 | 18/3/18
Voice Of Analysts
Zillow Group, Inc. (Z) stock managed performance 6.20% over the last week and switched with performance of 24.78% throughout past one month period.
more»
Zillow Group, Inc. (NASDAQ:Z) has analysts on the Bullish side this week.
00:37 | 18/3/18
Frisco Fastball
Among 10 analysts covering Zillow Inc (NASDAQ:Z), 6 have Buy rating, 0 Sell and 4 Hold. Therefore 60% are positive. Zillow Inc had 28 analyst reports since July 31, 2015 according to SRatingsIntel.
more»
Zillow Group, Inc. (Z) Can't Burn Your Long Portfolio. Just Reaches 52-Week High
05:41 | 16/3/18
Frisco Fastball
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in.
more»
Noteworthy Movers: Zillow Group, Inc. (NASDAQ:Z), Entegris, Inc. (NASDAQ:ENTG)
03:15 | 16/3/18
The Oracle Examiner
The company's brands focus on home lifecycle consists of renting, buying, selling, financing and home improvement. Its real estate and rental marketplaces of consumer brands includes Zillow(R), Trulia(R), StreetEasy(R) and HotPads(R).
more»
Their Current Valuation Deserve Consideration: Amicus Therapeutics, Inc. (FOLD ...
02:43 | 14/3/18
Post Analyst
Here's what's interesting to note about Amicus Therapeutics, Inc. (NASDAQ:FOLD) right now: Its price-to-sales ratio of 67.13, is expensive relative to the Biotechnology universe at large.
more»
Comments
There are currently no comments on this topic.
Be the first person to Add a Comment...
ADD USER TO MY FAVOURITE
Customize your favourite:
Send me an alert when this user publishes new articles.
Add a Comment
You must be a registered user to post a comment:
REGISTER NOW
If you are already registered, please
LOGIN NOW
Add to Watchlist
Add to Portfolio
Add Email Alert
Global Indices
Code
Last
Change
COMP
10,321
328
3.08%
DJI
29,635
404
1.34%
SP500
3,583
87
2.37%
DAX
12,438
82
0.67%
FTSE
7,488
5
0.07%
NI225
22,420
408
1.86%
TWI
67.27
0.00
0.00%
Most Viewed Stories
More news...
No news available...
Currencies
Code
Last
Change
EURUSD
0.9721
0.0055
0.56%
NZDUSD
0.5548
0.0093
1.65%
AUDUSD
0.6194
0.0107
1.70%
NZDAUD
0.8964
0.0010
0.11%
Newsletters
Email Address:
Weekly Newsletter
Daily Market Report
Daily Forex Report
Daily Global Report